SynBiotic SE (DUSE:SBX) acquired Ilesol Pharmaceuticals d.o.o. za proizvodnju i usluge on April 23, 2024. With the acquisition of Ilesol, SYNBIOTIC will be able to produce CBD isolates with the "Made in EU" label and distribute them through the companies of the SYNBIOTIC Group.

SynBiotic SE (DUSE:SBX) completed the acquisition of Ilesol Pharmaceuticals d.o.o. za proizvodnju i usluge on April 23, 2024.